Repeat complete blood count showed that lymphocytes and thrombocytes had returned to normal, along with serum creatinine and alanine transaminase
Groups Treatment Aspartate Transaminase (iu/l) I 100 mg/kg BJME 38.00 [+ or -] 5.83 * II 200 mg/kg BJME 35.50 [+ or -] 299 * III 300 mg/kg BJME 41.50 [+ or -] 2.99 ($) * IV 400 mg/kg BJME 40.25 [+ or -] 2.39 ($) * V 2ml/kg Tween 80 28.25 [+ or -] 3.71 VI Water 20.50 [+ or -] 0.65 F-ratio 5.504 Sig 0.003 Parameters Groups Alanine transaminases
Alkaline phosphatase (iu/l) (iu/l) I 89.75 [+ or -] 14.10 * 81.68 [+ or -] 21.70 II 51.25 [+ or -] 11.32 79.43 [+ or -] 20.33 III 82.25 [+ or -] 13.55 ($) * 63.05 [+ or -] 14.93 IV 73.75 [+ or -] 17.23 * 45.90 [+ or -] 1622 V 41.50 [+ or -] 2.33 57.25 [+ or -] 5.48 VI 3875 [+ or -] 0.85 64.75 [+ or -] 11.83 3.525 0.712 0.021 0.622 Data expressed in mean [+ or -] SEM; * and $- p<0.05 when compared to the groups V and VI respectively
Swansea diagnostic criteria  Laboratory Clinical Bilirubin >14 [micro]mol/L Vomiting Hypoglycaemia <4 mmol/L Abdominal pain Uric acid >340 [micro]mol/L Polydipsia and polyuria Leukocytosis >11x[10.sup.6]/L Encephalopathy AST/ALT >42 IU/L Ammonia >47 [micro]mol/L Creatinine >150 [micro]mol/L Coagulopathy, PT >14 s Laboratory Other Bilirubin >14 [micro]mol/L Ultrasound showing ascites/bright liver Hypoglycaemia <4 mmol/L Histology showing microvesicular steatosis Uric acid >340 [micro]mol/L Leukocytosis >11x[10.sup.6]/L AST/ALT >42 IU/L Ammonia >47 [micro]mol/L Creatinine >150 [micro]mol/L Coagulopathy, PT >14 s AST = aspartate transaminase; ALT = alanine transaminase
; PT = prothrombin time.
glucose, total protein, albumin, blood urea nitrogen (BUN), triglyceride, creatinine, alanine transaminase
(ALT) and aspartate transaminase (AST) in amniotic fluid of the experimental rabbits.
The level of serum alkaline phosphatase (913 IU/L), gamma-glutamyl transpeptidase (1109 U/L), aspartate transaminase (178 U/L), alanine transaminase
(280 U/L), and C-reactive protein (2.2 mg/dL) were markedly elevated.
Her laboratory values on transfer to our hospital were notable for a lipase of 161 U/L, alanine transaminase
of 335 U/L, aspartate transaminase of 214 U/L, and total bilirubin of 1.7 mg/dL.
Biochemical parameters such as aspartate transaminase (AST), alanine transaminase
(ALT), total protein, albumin, total bilirubin, direct bilirubin, blood urea nitrogen and creatinine.
Results: Overall alanine transaminase
and aspartate transaminase (ALT and AST) were raised, i.e.
Statistically significant reductions in live enzymes alanine transaminase
and aspartate transaminase were demonstrated in both Aramchol arms vs.
RBC morphology revealed microcytic hypochromic picture, prothrombin time 17/14, partial thromboplastin time 50/34, serum bilirubin 10 umol/l, alanine transaminase
(ALT) 23U/L, alkaline phosphatase 296 IU//L, urea 3.9 mmol/L.
The findings, by SRL Diagnostics, showed that young adults had more abnormalities in liver enzymes, known as aminotransferases, which include alanine transaminase
(ALT or SGPT) and aspartate transaminase (AST or SGOT).
She also proposed risk features to identify those infected with herpes simplex virus; age less than 42 days, vesicular rash, elevated alanine transaminase
(ALT) and aspartate aminotransferase (AST), CSF pleocytosis, and seizure or twitching.